Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 688 of 1,261
  1. US 9371375

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  2. US 9371368

    Compositions and methods for immunomodulation in an organism

    UNIVERSITY OF CONNECTICUT · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  3. US 9371336

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  4. US 9370581

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  5. US 9364509

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  6. US 9365610

    Asymmetric ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  7. US 9364501

    Chlorite in the treatment of neurodegenerative disease

    The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  8. US 9365566

    Cinnoline derivatives

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  9. US 9365557

    Substituted pyrazin-2-amines as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  10. US 9365549

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  11. US 9365581

    Deuterated amlexanox

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  12. US 9365545

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  13. US 9365520

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  14. US 9365504

    Salts of kukoamine B, preparation method and use thereof

    THE FIRST AFFILIATED HOSPITAL, THIRD MILITARY UNIVERSITY, PLA · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  15. US 9364406

    Open chained or fused 1,1′-alkylene-bis-uracil derivatives, useful in skin UV-protection

    Regents of the University of Minnesota · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  16. US 9364540

    Inhalable medicament

    Teva Branded Pharmaceutical Products R&D, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  17. US 9364563

    Methods and compositions for liposomal formulation of antigens and uses thereof

    The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  18. US 9364535

    Methods and compositions for modulating lymphangiogenesis, e.g., to treat transplant rejection, in a subject

    The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  19. US 9364521

    Human tissue kallikrein 1 glycosylation isoforms

    DiaMedica Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  20. US 9364505

    Therapeutic composition for treatment of glioblastoma

    Regents of the University of Minnesota · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  21. US 9365849

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  22. US 9365630

    Compositions and methods for Immunomodulation in an organism

    UNIVERSITY OF CONNECTICUT · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  23. US 9364430

    Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol

    Relmada Therapeutics, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  24. US 9365848

    Modulation of apolipoprotein C-III expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.